| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/12/2010 | US20100203008 Novel compositions for the treatment of verious inflammatory conditions |
| 08/12/2010 | US20100203007 Novel benzodiazepine derivatives |
| 08/12/2010 | US20100203004 Cosmetic composition containing a tensioning agent and an acrylic polymer |
| 08/12/2010 | US20100202983 Selectively targeted antimicrobials for the treatment of periodontal disease |
| 08/12/2010 | US20100202982 Oral Composition Containing Interferon-Alpha |
| 08/12/2010 | US20100202967 Fibrin binding pepetide conjugates for diagnostic and therapeutic applications |
| 08/12/2010 | US20100202964 Organ Homing Genes of Cancer Metastases |
| 08/12/2010 | US20100202963 Therapies for hematologic malignancies |
| 08/12/2010 | US20100202961 Immunological reagents for therapeutic use, in radioimmunotherapy (RAIT), and diagnostic use, in radioimmunodetection (RAID) and magnetic resonance imaging; conjugated drug as antiinflammatory, or anticarcinogenic agents; drug targets; tissue-targeted therapy |
| 08/12/2010 | CA2751865A1 Trimeric hiv fusion inhibitors for treating or preventing hiv infection |
| 08/12/2010 | CA2751807A1 Pharmaceutical composition for treating adverse reactions by administering spiegelmers |
| 08/12/2010 | CA2751679A1 Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy |
| 08/12/2010 | CA2751531A1 Vector(s) containing an inducible gene encoding a cdk4/cdk6 inhibitor useful for treating neurodegenerative disorders or diseases associated with an unscheduled activation of thecell cycle |
| 08/12/2010 | CA2751500A1 Grass peptides for vaccine |
| 08/12/2010 | CA2751445A1 Truncated cystine-knot proteins |
| 08/12/2010 | CA2750883A1 Actagardine derivatives |
| 08/12/2010 | CA2750469A1 Method and compositions for treating skin |
| 08/12/2010 | CA2749965A1 Methods and compositions for treating neuropathies |
| 08/12/2010 | CA2748921A1 Bortezumib containing pharmaceutical composition |
| 08/12/2010 | CA2746425A1 Clostridial toxin pharmaceutical compositions |
| 08/12/2010 | CA2726232A1 Stable formulation of a therapeutic protein |
| 08/11/2010 | EP2216409A1 Albumin fusion proteins |
| 08/11/2010 | EP2216343A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/11/2010 | EP2216043A1 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence |
| 08/11/2010 | EP2216042A1 GLP-1 analogues pharmaceutical compositions |
| 08/11/2010 | EP2216041A1 Method for induction of cytotoxic t-cell, cytotoxic t-cell inducer, and pharmaceutical composition and vaccine each comprising the inducer |
| 08/11/2010 | EP2216037A1 Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink |
| 08/11/2010 | EP2215268A1 Adiponectin receptor fragments and methods of use |
| 08/11/2010 | EP2215264A1 Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using mfg-e8 |
| 08/11/2010 | EP2215126A2 Compositions and methods to modulate cell membrane resealing |
| 08/11/2010 | EP2215114A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 08/11/2010 | EP2215111A2 Hla-dr binding peptides and their uses |
| 08/11/2010 | EP2215108A2 Competitive inhibitors of invariant chain expression and/or ectopic clip binding |
| 08/11/2010 | EP2215107A1 Peptide ligand directed drug delivery |
| 08/11/2010 | EP2214701A2 Compositions and methods of enhancinc immune responses to eimeria |
| 08/11/2010 | EP2214700A1 Semi-synthetic glp-1 peptide-fc fusion constructs, methods and uses |
| 08/11/2010 | EP2214699A2 Method, composition, and article of manufacture for providing alpha-1 antitrypsin |
| 08/11/2010 | EP2214698A2 Use of compounds activating sirt-3 for mimicking exercise |
| 08/11/2010 | EP2214697A2 Nell-1 compositions |
| 08/11/2010 | EP2214696A1 Methods of treating chronic neurogenic inflammation using modified clostridial toxins |
| 08/11/2010 | EP2214695A2 Novel use |
| 08/11/2010 | EP2214694A1 Compositions for reducing dental erosion |
| 08/11/2010 | EP2214692A2 Use of toll-like receptor 4 antagonists for the treatment or prevention of osteoarthritic conditions |
| 08/11/2010 | EP2214691A1 Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| 08/11/2010 | EP2214690A1 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 08/11/2010 | EP2214647A2 Delivery of active agents |
| 08/11/2010 | EP2214645A2 Liposomal vancomycin formulations |
| 08/11/2010 | EP2214641A1 A scalable matrix for the in vivo cultivation of bone and cartilage |
| 08/11/2010 | EP1984522B1 Methods of increasing lymphatic function |
| 08/11/2010 | EP1911763B1 Compositions for the treatment of gastrointestinal disorders |
| 08/11/2010 | EP1881020B1 Polymeric derivative of cytidine metabolic antagonist |
| 08/11/2010 | EP1812076B1 Platelet-derived growth factor compositions and methods of use thereof |
| 08/11/2010 | EP1796647B1 Stable pegylated interferon formulation |
| 08/11/2010 | EP1604010B1 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ICAM-1 |
| 08/11/2010 | EP1531791B1 Prevention and reduction of ischemia |
| 08/11/2010 | EP1499294B1 Polymerized lipids modified with peptides used as delivery system for micronutrients |
| 08/11/2010 | EP1489170B1 Transporter selectively transporting sulfate conjugate and its gene |
| 08/11/2010 | EP0672160B1 Activating expression of an amplifying endogenous gene by homologous recombination |
| 08/11/2010 | CN1876833B Anti-HIV agent evaluation method |
| 08/11/2010 | CN1817909B Double-functional blended protein |
| 08/11/2010 | CN1698879B Product having sobering up and liver protecting functions and its preparation method and usage |
| 08/11/2010 | CN1680427B Water soluble piduomode composite salt and its preparation |
| 08/11/2010 | CN101802211A Anti-RANTES antibodies and methods of use thereof |
| 08/11/2010 | CN101802199A Promoterless cassettes for expression of alphavirus structural proteins |
| 08/11/2010 | CN101802185A truncated secretory aspartyl proteinase 2 |
| 08/11/2010 | CN101802184A Meganuclease variants cleaving a DNA target sequence from the human hemoglobin beta gene and uses thereof |
| 08/11/2010 | CN101802001A Igf-1r binding proteins and antagonists |
| 08/11/2010 | CN101801996A Optimized dengue virus entry inhibitory peptide (DN81) |
| 08/11/2010 | CN101801406A Tissue kallikrein for the treatment of diseases associated with amyloid protein |
| 08/11/2010 | CN101801405A Protein formulations comprising GDF-5 in aqueous acidic solution |
| 08/11/2010 | CN101801404A Protein formulations for use at elevated temperatures |
| 08/11/2010 | CN101801403A Human EPO receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions |
| 08/11/2010 | CN101801402A Treatment and prevention of inflammatory diseases and autoimmune diseases |
| 08/11/2010 | CN101801401A Kinase protein binding inhibitors |
| 08/11/2010 | CN101801360A Pulmonary delivery of spherical insulin microparticles |
| 08/11/2010 | CN101799476A Reagent box for sieving autoantibody for tsh receptor |
| 08/11/2010 | CN101798346A Long-acting recombinant human tissue factor pathway inhibitor expressed by yeast |
| 08/11/2010 | CN101798338A Anti-opioid peptide antagonist peptide and application thereof |
| 08/11/2010 | CN101798337A Mutant of endotoxin neutralizing peptide and application thereof |
| 08/11/2010 | CN101798336A Anti-tumour compound with tracking function |
| 08/11/2010 | CN101797384A Tri-union compound immunopotentiator and method for preparing same |
| 08/11/2010 | CN101797379A Combination humidifying liquor for ultrasonic atomization therapy |
| 08/11/2010 | CN101797378A Hemostasis composition containing batroxobin and preparation method thereof |
| 08/11/2010 | CN101797377A Fibrin sealant and preparation method thereof |
| 08/11/2010 | CN101797376A Preparation method of modified collagen film |
| 08/11/2010 | CN101797375A Application of MG53 protein for preventing and/or treating myocardial ischemia/reperfusion injury |
| 08/11/2010 | CN101797374A Compound minocycline hydrochloride soluble powder for treating respiratory diseases of poultry |
| 08/11/2010 | CN101797373A Application of marine peptide in preparing medicament for promoting caesarean section postoperation recovery and health food |
| 08/11/2010 | CN101797304A Gel for adjusting microecology in vaginas of women |
| 08/11/2010 | CN101797234A Pramlintide acetate slow release microballoon preparation and preparation method thereof |
| 08/11/2010 | CN101797232A Method for preparing small-granularity recombination human vascular endothelium inhibin slowly-released particle for injection |
| 08/11/2010 | CN101301476B Hydrophobic cyclodextrin clathrate and preparation and use thereof |
| 08/11/2010 | CN101240030B Conjugate constructed from normal undecyl and RGD peptide, and its synthesis and application in medicine |
| 08/11/2010 | CN101240029B Conjugate constructed from normal heptyl and RGD peptide, and its synthesis method and application |
| 08/11/2010 | CN101219208B Medicine use of interleukin-22 |
| 08/11/2010 | CN101161674B Cyclopeptide, preparation method and uses thereof |
| 08/11/2010 | CN100999546B Polypeptide compound with aza-containing heterocyclic modification and its application |
| 08/10/2010 | US7772427 Uses for amino acid anticonvulsants |
| 08/10/2010 | US7772397 derivatives of Hemiasterlin or Geodiamolide G; pyrido(3,4-B)indole amides; extraction from marine sponges; anti-mitotic and carcinogenic agent; cause mitotic arrest and produce abnormal mitotic spindles |
| 08/10/2010 | US7772386 immunization against Mycobacterium tuberculosis; purified nucleic acid molecule coding for oxidoreductase from M. tuberculosis; production of a vaccine against a virulent strain of M. tuberculosis |